论文部分内容阅读
目的:观察布地奈德雾化吸入治疗小儿急性喉炎的临床疗效。方法:选择2007-09/2008-09急性喉炎患儿96例,随机分为治疗组(48例)和对照组(48例)。在相同的综合性治疗及一般对症处理基础上,对照组采用静脉滴注地塞米松0.2~0.3 mg/(kg.d),连用3 d;治疗组给予空气压缩泵雾化吸入布地奈德混悬液,每次2 ml,每次10~15 min,3次/d,连用3 d。结果:治疗组经治疗后症状、体征改善及消失天数等各项指标,均明显优于对照组,两组比较差异有统计学意义(P<0.01)。结论:局部雾化吸入布地奈德治疗小儿急性喉炎疗效确切,使用方便。
Objective: To observe the clinical efficacy of budesonide inhalation in the treatment of acute laryngitis in children. Methods: Ninety-six children with acute laryngitis from 2007-09 / 2008-09 were randomly divided into treatment group (48 cases) and control group (48 cases). On the basis of the same comprehensive treatment and general symptomatic treatment, the control group was treated with 0.2-0.3 mg / (kg.d) dexamethasone intravenously for 3 days. The treatment group was given air compression pump to inhale budesonide mixture Suspension, each 2 ml, each 10 ~ 15 min, 3 times / d, once every 3 d. Results: After treatment, the symptoms, signs and days disappeared in the treatment group were significantly better than the control group, the difference between the two groups was statistically significant (P <0.01). Conclusion: The local inhalation of budesonide in children with acute laryngitis is effective and easy to use.